Breaking News Instant updates and real-time market news.

MA

MasterCard

$141.72

-0.52 (-0.37%)

07:17
09/22/17
09/22
07:17
09/22/17
07:17

MasterCard price target raised to $156 from $140 at RBC Capital

RBC Capital analyst Daniel Perlin increased his price target on MasterCard based on multiple positive catalysts. Among the catalysts he cited were improved macro trends, a more favorable revenue growth/spending growth ratio, innovation, and the expansion of its total available market through strategic acquisitions and new products. Perlin keeps an Outperform rating on the shares.

  • 22

    Oct

MA MasterCard
$141.72

-0.52 (-0.37%)

09/19/17
MSCO
09/19/17
NO CHANGE
Target $160
MSCO
Overweight
MasterCard price target raised to $160 from $138 at Morgan Stanley
Morgan Stanley analyst James Faucette believes MasterCard can deliver slightly accelerating organic revenue growth in 2018, which could be the beginning of an accelerating growth period. While the market is not fully appreciating benefits to MasterCard from factors including the secular shift to e-commerce and e-payments and growing demand for service like fraud detection and remediation, worries about disintermediation are likely overdone, said Faucette, who raised his price target on the stock to $160 from $138 and keeps an Overweight rating on the shares.
09/11/17
09/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. MasterCard (MA) upgraded to Buy from Neutral at Guggenheim. 2. FireEye (FEYE) upgraded to Overweight from Equal Weight at Stephens with analyst Jonathan Ruykhaver saying he believes consensus expectations are modeling a decline in product revenue this year, though he thinks this is too low given the refresh opportunity from appliance sales about 3 years ago. 3. Teva (TEVA) upgraded to Buy from Neutral at BTIG with analyst Timothy Chiang saying the company's appointment of Kare Schultz as its new CEO is "a positive catalyst that should help create a floor for the shares and provide a boost to near-term investor sentiment." 4. Incyte (INCY) upgraded to Outperform from Market Perform at Raymond James with analyst Reni Benjamin citing increased confidence in the probability of success of the ongoing Phase III ECHO-301, Epa plus pembrolizumab study, the commercial prospects of the Epa franchise in melanoma and at least four other tumor types, as well as the U.S. commercial opportunity for baricitinib. 5. QuickLogic (QUIK) upgraded to Buy from Neutral at Roth Capital with analyst Suji Desilva saying he believes its revenues are better positioned for upside revisions. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/11/17
GUGG
09/11/17
UPGRADE
GUGG
Buy
MasterCard upgraded to Buy from Neutral at Guggenheim
09/08/17
FBCO
09/08/17
NO CHANGE
Target $145
FBCO
Outperform
MasterCard price target raised to $145 from $128 at Credit Suisse
Credit Suisse analyst Moshe Orenbuch raised his estimates for MasterCard after the company increased its revenue expectations at its annual investor day, noting that management highlighted recent momentum in U.S. consumer credit and seems prepared to displace current ACH competition in Europe. Orenbuch upped his price target on MasterCard to $145 from $128 and keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

BA

Boeing

$264.75

5.71 (2.20%)

05:25
10/23/17
10/23
05:25
10/23/17
05:25
Hot Stocks
Boeing, Mitsubishi Heavy reach agreement on cost reduction for 787 production »

Boeing and Mitsubishi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

BAC

Bank of America

$27.17

0.59 (2.22%)

05:24
10/23/17
10/23
05:24
10/23/17
05:24
Hot Stocks
Merrill Lynch fined $45.5M in Britain for not reporting derivative transactions »

Bank of America's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ATHN

athenahealth

$126.04

9.63 (8.27%)

05:18
10/23/17
10/23
05:18
10/23/17
05:18
Upgrade
athenahealth rating change  »

athenahealth upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TATYY

Tate & Lyle

$33.23

-0.835 (-2.45%)

05:13
10/23/17
10/23
05:13
10/23/17
05:13
Upgrade
Tate & Lyle rating change  »

Tate & Lyle upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$48.37

0.24 (0.50%)

05:12
10/23/17
10/23
05:12
10/23/17
05:12
Downgrade
Rio Tinto rating change  »

Rio Tinto downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MELI

MercadoLibre

$235.73

-0.27 (-0.11%)

05:02
10/23/17
10/23
05:02
10/23/17
05:02
Recommendations
MercadoLibre analyst commentary  »

MercadoLibre price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$338.10

-4.32 (-1.26%)

04:59
10/23/17
10/23
04:59
10/23/17
04:59
Initiation
Biogen initiated  »

Biogen assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

CELG

Celgene

$121.33

-14.63 (-10.76%)

04:56
10/23/17
10/23
04:56
10/23/17
04:56
Downgrade
Celgene rating change  »

Celgene assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

04:55
10/23/17
10/23
04:55
10/23/17
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

ASOMY

ASOS

$74.28

1.5 (2.06%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
ASOS management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

04:55
10/23/17
10/23
04:55
10/23/17
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

04:55
10/23/17
10/23
04:55
10/23/17
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

PAY

Verifone

$20.06

0.06 (0.30%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
Verifone management to meet with Jefferies »

Meeting to be held in Las…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 14

    Dec

PLUG

Plug Power

$2.70

0.17 (6.72%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
Plug Power to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 16

    Nov

DDAIF

Daimler AG

$80.57

-1.11 (-1.36%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
Daimler AG management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

04:55
10/23/17
10/23
04:55
10/23/17
04:55
General news
Chicago Fed National Activity Index Level to be reported at 08:30 »

September Chicago Fed…

IVC

Invacare

$14.60

0.05 (0.34%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
Invacare management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ALXN

Alexion

$139.02

-1.44 (-1.03%)

04:54
10/23/17
10/23
04:54
10/23/17
04:54
Initiation
Alexion initiated  »

Alexion assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 26

    Oct

  • 06

    Nov

BIVV

Bioverativ

$60.22

0.49 (0.82%)

04:52
10/23/17
10/23
04:52
10/23/17
04:52
Initiation
Bioverativ initiated  »

Bioverativ assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 06

    Nov

TSRO

Tesaro

$116.40

0.89 (0.77%)

04:50
10/23/17
10/23
04:50
10/23/17
04:50
Downgrade
Tesaro rating change  »

Tesaro assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

  • 08

    Nov

AMAG

Amag Pharmaceuticals

$15.60

-0.45 (-2.80%)

04:48
10/23/17
10/23
04:48
10/23/17
04:48
Initiation
Amag Pharmaceuticals initiated  »

Amag Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 02

    Feb

  • 14

    Feb

04:15
10/23/17
10/23
04:15
10/23/17
04:15
General news
FX Action: USD-CAD has remained underpinned »

FX Action: USD-CAD has…

03:05
10/23/17
10/23
03:05
10/23/17
03:05
General news
FX Update: The dollar has traded mixed »

FX Update: The dollar has…

HAL

Halliburton

$43.33

-0.09 (-0.21%)

, VFC

VF Corp.

$66.38

1.03 (1.58%)

20:25
10/22/17
10/22
20:25
10/22/17
20:25
Earnings
Notable companies reporting before Monday's open »

Notable companies…

HAL

Halliburton

$43.33

-0.09 (-0.21%)

VFC

VF Corp.

$66.38

1.03 (1.58%)

STT

State Street

$99.12

1.64 (1.68%)

STX

Seagate

$34.94

0.6 (1.75%)

SALT

Scorpio Bulkers

$8.20

0.45 (5.81%)

LOGI

Logitech

$36.71

0.1 (0.27%)

ITW

Illinois Tool Works

$155.03

1.55 (1.01%)

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

HAS

Hasbro

$98.19

1.52 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

LGF.A

Lionsgate

$30.09

-0.08 (-0.27%)

, FB

Facebook

$174.98

0.42 (0.24%)

20:10
10/22/17
10/22
20:10
10/22/17
20:10
Hot Stocks
Catch up on the weekend's top five stories with this list compiled by The Fly: »

1. Tesla has reached an…

LGF.A

Lionsgate

$30.09

-0.08 (-0.27%)

FB

Facebook

$174.98

0.42 (0.24%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

COH

Coach

$40.35

0.88 (2.23%)

DWDP

DowDuPont

$71.18

0.29 (0.41%)

CZR

Caesars

$12.20

0.15 (1.24%)

DAL

Delta Air Lines

$53.27

1 (1.91%)

AAL

American Airlines

$51.93

0.42 (0.82%)

DLAKY

Lufthansa

$30.28

0.2 (0.66%)

SSNLF

Samsung

MS

Morgan Stanley

$50.68

0.89 (1.79%)

UAL

United Continental

$59.90

0.12 (0.20%)

TSLA

Tesla

$345.10

-6.71 (-1.91%)

AET

Aetna

$160.84

3.2 (2.03%)

ANTM

Anthem

$194.69

1.49 (0.77%)

CNC

Centene

$96.50

1.8 (1.90%)

CI

Cigna

$191.42

3.2 (1.70%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

WCG

WellCare

$180.52

3.28 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 08

    Nov

  • 09

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.